Radovanović Zoran, Radovanović Dragana, Breberina Milan, Petrović Tomislav, Golubović Andrija, Bokorov Bojana
Institut za onkologiju Vojvodine, Klinika za operativnu onkologiju, Sremska Kamenica.
Med Pregl. 2008 Nov-Dec;61(11-12):557-61. doi: 10.2298/mpns0812557r.
Preoperative staging of rectal cancer is considered essential to select patients adequately for different therapeutic regimes. The aim of the present study was to evaluate the accuracy of endorectal ultrasonography in preoperative staging of rectal cancer.
Fifty rectal cancer patients (31 men, 19 women) underwent endorectal ultrasonography with a 7.5-MHz probe. Thirty-eight of these patients had preoperative chemoradiation and in these patients examination was done before and after the radiotherapy treatment. The results of examinations were compared with the histological findings of the resected specimens.
Histopathology showed 4 stage TO, 3 stage T1, 12 stage T2, 30 stage T3, and one stage T4 tumor. Nodal metastases were seen in 17 patients. The overall accuracy of endorectal ultrasonography for determining the depth of invasion (T stage) was 66% (33/50). The accuracy rate of T1 was 100% (1/1), T2 was 45% (9/20), T3 was 79% (22/28), and T4 was 100% (1/1). Overstaging was 18% (9/50) and understaging 16% (8/50). In staging lymph node metastasis, the overall accuracy rate was 70% (18/25) with 18% (9/50) overstaged and 12% (6/50) understaged With regard to nodal involvement, sensitivity was 65% and specificity 73%. Regarding penetration of the rectal wall (stages T1 and T2 vs stages T3 and T4/Dukes' classification A versus B), endorectal sonography showed sensitivity, specificity, and accuracy of 74%, 68%, and 72%, respectively.
Endorectal ultrasonography is a valuable diagnostic modality for rectal cancer staging. It is fast, safe, accurate, well tolerated by the patient and cheap procedure and therefore should be used as a diagnostic modality of the first choice in rectal cancer staging although one must take into consideration possible limitations in cases of preoperative chemoradiation.
直肠癌的术前分期被认为对于为不同治疗方案充分选择患者至关重要。本研究的目的是评估直肠内超声检查在直肠癌术前分期中的准确性。
50例直肠癌患者(31例男性,19例女性)接受了使用7.5MHz探头的直肠内超声检查。其中38例患者术前接受了放化疗,这些患者在放疗前后均进行了检查。将检查结果与切除标本的组织学结果进行比较。
组织病理学显示4例T0期、3例T1期、12例T2期、30例T3期和1例T4期肿瘤。17例患者出现淋巴结转移。直肠内超声检查确定浸润深度(T分期)的总体准确率为66%(33/50)。T1期的准确率为100%(1/1),T2期为45%(9/20),T3期为79%(22/28),T4期为100%(1/1)。分期过高为18%(9/50),分期过低为16%(8/50)。在分期淋巴结转移方面,总体准确率为70%(18/25),分期过高为18%(9/50),分期过低为12%(6/50)。关于淋巴结受累,敏感性为65%,特异性为73%。关于直肠壁穿透(T1和T2期与T3和T4期/杜克分期A与B),直肠内超声检查的敏感性、特异性和准确率分别为74%、68%和72%。
直肠内超声检查是直肠癌分期的一种有价值的诊断方法。它快速、安全、准确,患者耐受性好且费用低廉,因此应作为直肠癌分期的首选诊断方法,尽管在术前放化疗的情况下必须考虑到可能的局限性。